COM:ANAVEX
Anavex Life Sciences Corp.
- Stock
Last Close
9.02
22/11 21:00
Market Cap
391.04M
Beta: -
Volume Today
1.95M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '14 | Sep '15 | Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -11.37M - | -12.11M 6.51% | -14.74M 21.71% | -13.46M 8.66% | -17.45M 29.66% | -26.29M 50.66% | -26.28M 0.06% | -37.91M 44.25% | -47.98M 26.56% | -47.51M 0.99% | |
depreciation and amortization | 768 - | 995 29.56% | 1.25K 25.83% | ||||||||
deferred income tax | 5.56M - | 482.16K 91.34% | -58.14K 112.06% | ||||||||
stock based compensation | 637.92K - | 1.63M 156.14% | 5.06M 209.81% | 4.14M 18.31% | 5.52M 33.40% | 6.43M 16.56% | 4.88M 24.16% | 8.23M 68.78% | 18.38M 123.28% | 16.37M 10.93% | |
change in working capital | -336.25K - | 1.24M 468.08% | 640.07K 48.29% | 382.81K 40.19% | -646.00K 268.75% | 1.30M 301.49% | 116.52K 91.05% | -706.44K 706.30% | 5.36M 858.85% | 2.50M 53.27% | |
accounts receivables | -772.39K - | -2.21M 185.68% | -4.29M 94.30% | 5.94M 238.64% | 484K 91.86% | ||||||
inventory | 772.39K - | 2.21M 185.68% | 4.29M 94.30% | -5.94M 238.64% | -484K 91.86% | ||||||
accounts payables | -151.40M - | 683.80K - | 465.72K 31.89% | 750.73K 61.20% | -915.00K 221.88% | 497K 154.32% | |||||
other working capital | -336.25K - | 1.24M 468.08% | 152.04M 12,184.36% | 382.81K 99.75% | -646.00K 268.75% | 617.82K 195.64% | -349.20K 156.52% | -1.46M 317.28% | 6.28M 530.69% | 2.01M 68.00% | |
other non cash items | 2.84M - | 4.53M 59.29% | -145.57K 103.22% | -75.20K 48.34% | 35.38K - | 845K - | |||||
net cash provided by operating activities | -2.66M - | -4.23M 58.95% | -9.24M 118.52% | -9.02M 2.38% | -12.58M 39.54% | -18.53M 47.25% | -21.29M 14.90% | -30.38M 42.73% | -24.24M 20.23% | -27.79M 14.63% | |
investments in property plant and equipment | -3.02K - | ||||||||||
acquisitions net | |||||||||||
purchases of investments | |||||||||||
sales maturities of investments | |||||||||||
other investing activites | |||||||||||
net cash used for investing activites | -3.02K - | ||||||||||
debt repayment | -88.14K - | -34.76K 60.57% | |||||||||
common stock issued | 368.17K - | 12.34M 3,252.80% | 3.17M 74.34% | 27.27M 760.97% | 8.17M 70.03% | 17.83M 118.16% | 28.75M 61.25% | 153.22M 432.86% | 20.98M 86.30% | 27.88M 32.84% | |
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 9.21M - | -101.13K - | -50K 50.56% | -403.76K 707.53% | 23.64K 105.85% | 303.31K 1,183.10% | 1.78M 485.53% | ||||
net cash used provided by financing activities | 9.58M - | 12.26M 27.94% | 3.13M 74.44% | 27.27M 770.53% | 8.07M 70.40% | 17.78M 120.27% | 28.35M 59.43% | 153.24M 440.53% | 21.29M 86.11% | 29.65M 39.29% | |
effect of forex changes on cash | |||||||||||
net change in cash | 6.92M - | 8.03M 16.07% | -6.10M 176.03% | 18.25M 399.03% | -4.51M 124.71% | -745.01K 83.48% | 7.06M 1,048.10% | 122.86M 1,639.37% | -2.95M 102.40% | 1.87M 163.26% | |
cash at beginning of period | 345.07K - | 7.26M 2,004.52% | 15.29M 110.56% | 9.19M 39.92% | 27.44M 198.69% | 22.93M 16.43% | 22.19M 3.25% | 29.25M 31.84% | 152.11M 420.04% | 149.16M 1.94% | |
cash at end of period | 7.26M - | 15.29M 110.56% | 9.19M 39.92% | 27.44M 198.69% | 22.93M 16.43% | 22.19M 3.25% | 29.25M 31.84% | 152.11M 420.04% | 149.16M 1.94% | 151.02M 1.25% | |
operating cash flow | -2.66M - | -4.23M 58.95% | -9.24M 118.52% | -9.02M 2.38% | -12.58M 39.54% | -18.53M 47.25% | -21.29M 14.90% | -30.38M 42.73% | -24.24M 20.23% | -27.79M 14.63% | |
capital expenditure | -3.02K - | ||||||||||
free cash flow | -2.66M - | -4.23M 58.77% | -9.24M 118.52% | -9.02M 2.38% | -12.58M 39.54% | -18.53M 47.25% | -21.29M 14.90% | -30.38M 42.73% | -24.24M 20.23% | -27.79M 14.63% |
All numbers in USD (except ratios and percentages)